These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3839511)

  • 21. Analysis of the eicosapentaenoic acid (EPA) metabolite delta 17-6-keto-PGF1 alpha in human plasma by GC/SIM using [18O] delta 17-6-keto-PGF1 alpha.
    Mizugaki M; Nishikawa M; Hishinuma T; Ohyama Y; Ishibashi M
    Prostaglandins; 1992 Oct; 44(4):317-27. PubMed ID: 1438883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of 6-keto-prostaglandin E1 obtained from isolated perfused kidney of the rabbit.
    Pieroni JP; Dray F; Pace-Asciak CR; McGiff JC
    J Pharmacol Exp Ther; 1988 Oct; 247(1):63-8. PubMed ID: 3139870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A radioimmunoassay for 6-keto-prostaglandin F1 alpha.
    Demers LM; Derck DD
    Adv Prostaglandin Thromboxane Res; 1980; 6():193-9. PubMed ID: 6892975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Establishment of microanalysis of prostaglandin metabolites by GC/MS and its clinical application].
    Mizugaki M
    Yakugaku Zasshi; 1999 Jan; 119(1):61-80. PubMed ID: 9922710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NK1 receptors mediated release of 6-keto-PGF1 alpha from the ex vivo perfused canine ileum.
    Parrish MB; Rainsford KD; Johnson DM; Daniel EE
    J Pharmacol Exp Ther; 1994 Oct; 271(1):39-47. PubMed ID: 7525925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dexamethasone on in vivo prostanoid production in the rabbit.
    Náray-Fejes-Tóth A; Fejes-Tóth G; Fischer C; Frölich JC
    J Clin Invest; 1984 Jul; 74(1):120-3. PubMed ID: 6429194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different results of plasma 6-keto-prostaglandin F1 alpha measurements utilizing two antisera with apparently similar specificity.
    Viinikka L; Ylikorkala O
    Prostaglandins Leukot Med; 1982 Jul; 9(1):1-7. PubMed ID: 6957891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simple radioimmunological method for urinary 6-keto-PGF1 alpha measurement.
    Lahera V; Durán F; Cachofeiro V; del Cañizo FJ; Rodríguez FJ; Tresguerres JA
    Rev Esp Fisiol; 1986 Jun; 42(2):233-8. PubMed ID: 3755837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative analysis of 6-keto-prostaglandin F1 alpha using immunoaffinity purification and gas chromatography-mass spectrometry.
    Vrbanac JJ; Eller TD; Knapp DR
    J Chromatogr; 1988 Mar; 425(1):1-9. PubMed ID: 2452173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in urinary 6-keto-prostaglandin F1 alpha excretion during pregnancy and labor.
    Noort WA; de Zwart FA; Keirse MJ
    Prostaglandins; 1988 Apr; 35(4):573-82. PubMed ID: 3247472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostacyclin and thromboxane in pregnant and nonpregnant women in response to exercise.
    Rauramo I; Ilmonen S; Viinikka L; Ylikorkala O
    Obstet Gynecol; 1995 Jun; 85(6):1027-30. PubMed ID: 7770249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous solid phase extraction, derivatization, and gas chromatographic mass spectrometric quantification of thromboxane and prostacyclin metabolites, prostaglandins, and isoprostanes in urine.
    Wübert J; Reder E; Kaser A; Weber PC; Lorenz RL
    Anal Chem; 1997 Jun; 69(11):2143-6. PubMed ID: 9183177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous determination of 6-oxo-prostaglandin F1 alpha and 2,3-dinor-6-oxo-prostaglandin F1 alpha in biological fluids by stable isotope dilution and negative ion chemical ionization mass spectrometry.
    Fischer C; Meese CO
    Biomed Mass Spectrom; 1985 Aug; 12(8):399-404. PubMed ID: 2931130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostacyclin metabolism in adults and neonates. Urinary profiles of 6-ketoprostaglandin F1 alpha and 2,3-dinor-6-ketoprostaglandin F1 alpha studied by gas chromatography-mass spectrometry.
    Fischer S; Scherer B; Weber PC
    Biochim Biophys Acta; 1983 Jan; 750(1):127-33. PubMed ID: 6337642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of eicosapentaenoic acid (EPA) on prostacyclin production in diabetics: GC/MS analysis of PGI2 and PGI3 levels.
    Nishikawa M; Hishinuma T; Nagata K; Koseki Y; Suzuki K; Mizugaki M
    Methods Find Exp Clin Pharmacol; 1997; 19(6):429-33. PubMed ID: 9385592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a GC-MS method for quantitation of 2,3-dinor-6-keto-PGF1 alpha and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs.
    Vesterqvist O; Gréen K
    Prostaglandins; 1984 Jul; 28(1):139-54. PubMed ID: 6548317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of a LC/MS/MS method for 6-keto PGF1α, a metabolite of prostacyclin (PGI₂).
    Chappell DL; Xiao X; Radziszewski W; Laterza OF
    J Pharm Biomed Anal; 2011 Nov; 56(3):600-3. PubMed ID: 21782371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans.
    Schweer H; Watzer B; Seyberth HW; Nüsing RM
    J Mass Spectrom; 1997 Dec; 32(12):1362-70. PubMed ID: 9423285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma 6-keto-prostaglandin F1alpha: fact or fiction.
    Greaves M; Preston FE
    Thromb Res; 1982 May; 26(3):145-57. PubMed ID: 7051414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaginal and abdominal delivery increases maternal urinary 6-keto-prostaglandin F1 alpha excretion.
    Ylikorkala O; Paatero H; Suhonen L; Viinikka L
    Br J Obstet Gynaecol; 1986 Sep; 93(9):950-4. PubMed ID: 3768289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.